These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 15009855)

  • 1. QRS duration and shortening to predict clinical response to cardiac resynchronization therapy in patients with end-stage heart failure.
    Molhoek SG; VAN Erven L; Bootsma M; Steendijk P; Van Der Wall EE; Schalij MJ
    Pacing Clin Electrophysiol; 2004 Mar; 27(3):308-13. PubMed ID: 15009855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure.
    Mollema SA; Bleeker GB; van der Wall EE; Schalij MJ; Bax JJ
    Am J Cardiol; 2007 Dec; 100(11):1665-70. PubMed ID: 18036366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QRS frequency characteristics help predict response to cardiac resynchronization in left bundle branch block less than 150 milliseconds.
    Niebauer MJ; Rickard J; Polakof L; Tchou PJ; Varma N
    Heart Rhythm; 2014 Dec; 11(12):2183-9. PubMed ID: 25068573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective validation of stress echocardiography as an identifier of cardiac resynchronization therapy responders.
    Da Costa A; Thévenin J; Roche F; Faure E; Roméyer-Bouchard C; Messier M; Convert G; Barthélemy JC; Isaaz K
    Heart Rhythm; 2006 Apr; 3(4):406-13. PubMed ID: 16567286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Changes in QRS Frequency Following Cardiac Resynchronization Predict Hemodynamic Response in Left Bundle Branch Block Patients.
    Niebauer MJ; Rickard J; Tchou PJ; Varma N
    J Cardiovasc Electrophysiol; 2016 May; 27(5):594-9. PubMed ID: 26824741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Echocardiographic phase imaging to predict reverse remodeling after cardiac resynchronization therapy.
    Buss SJ; Humpert PM; Bekeredjian R; Hardt SE; Zugck C; Schellberg D; Bauer A; Filusch A; Kuecherer H; Katus HA; Korosoglou G
    JACC Cardiovasc Imaging; 2009 May; 2(5):535-43. PubMed ID: 19442937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy.
    Bax JJ; Bleeker GB; Marwick TH; Molhoek SG; Boersma E; Steendijk P; van der Wall EE; Schalij MJ
    J Am Coll Cardiol; 2004 Nov; 44(9):1834-40. PubMed ID: 15519016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New York Heart Association functional class, QRS duration, and survival in heart failure with reduced ejection fraction: implications for cardiac resychronization therapy.
    Braunschweig F; Linde C; Benson L; Ståhlberg M; Dahlström U; Lund LH
    Eur J Heart Fail; 2017 Mar; 19(3):366-376. PubMed ID: 27338764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac resynchronization therapy in patients with intrinsic and right ventricular pacing-induced left bundle branch block pattern.
    Shen X; Aronow WS; Holmberg MJ; Li H; Nair CK; Korlakunta H; Esterbrooks DJ
    Am J Ther; 2009; 16(6):e44-50. PubMed ID: 19940605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of QRS Duration to Response to Cardiac Resynchronization Therapy in Patients With Left Bundle Branch Block.
    Sassone B; Bertini M; Beltrami M; Malagù M; Pasanisi G; Kuwornu HA; Avigni N; Fucà G; Pacchioni F; Minarelli M; Bacchi Reggiani ML; Padeletti L
    Am J Cardiol; 2017 Jun; 119(11):1803-1808. PubMed ID: 28391991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probability and magnitude of response to cardiac resynchronization therapy according to QRS duration and gender in nonischemic cardiomyopathy and LBBB.
    Varma N; Manne M; Nguyen D; He J; Niebauer M; Tchou P
    Heart Rhythm; 2014 Jul; 11(7):1139-47. PubMed ID: 24704570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial dysfunction in heart failure identifies responders to cardiac resynchronization therapy.
    Akar JG; Al-Chekakie MO; Fugate T; Moran L; Froloshki B; Varma N; Santucci P; Wilber DJ; Matsumura ME
    Heart Rhythm; 2008 Sep; 5(9):1229-35. PubMed ID: 18774094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of cardiac resynchronization therapy in patients with end-stage heart failure.
    Molhoek SG; Bax JJ; Bleeker GB; Holman ER; Van Erven L; Bootsma M; Boersma E; Steendijk P; Van Der Wall EE; Schalij MJ
    J Cardiovasc Electrophysiol; 2005 Jul; 16(7):701-7. PubMed ID: 16050826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reverse electrical remodeling by cardiac resynchronization therapy: prevalence and clinical impact.
    Sebag FA; Martins RP; Defaye P; Hidden-Lucet F; Mabo P; Daubert JC; Leclercq C
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1219-27. PubMed ID: 22697464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of QRS duration to response to cardiac resynchronization therapy.
    Sassone B; Gambetti S; Bertini M; Beltrami M; Mascioli G; Bressan S; Fucà G; Pacchioni F; Pedaci M; Michelotti F; Bacchi Reggiani ML; Padeletti L
    Am J Cardiol; 2015 Jan; 115(2):214-9. PubMed ID: 25465934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of baseline electrocardiographic QRS complex pattern to predict response to cardiac resynchronization.
    Adelstein EC; Saba S
    Am J Cardiol; 2009 Jan; 103(2):238-42. PubMed ID: 19121443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of QRS duration and pacing location on pressure-volume loop evaluation of cardiac resynchronization therapy in end-stage heart failure.
    de Roest GJ; Allaart CP; de Haan S; Hendriks ML; Bronzwaer JG; van Rossum AC; de Cock CC
    Am J Cardiol; 2011 Dec; 108(11):1581-8. PubMed ID: 21890082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Shortest QRS Duration of an Electrocardiogram Might Be an Optimal Electrocardiographic Predictor for Response to Cardiac Resynchronization Therapy.
    Chen JY; Lin KH; Chang KC; Chou CY
    Int Heart J; 2017 Aug; 58(4):530-535. PubMed ID: 28701672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of QRS duration and axis on response to cardiac resynchronization therapy in chronic heart failure with reduced left ventricular ejection fraction: A single center study including patients with left bundle branch block.
    Fabiszak T; Łach P; Ratajczak J; Koziński M; Krupa W; Kubica J
    Cardiol J; 2020; 27(5):575-582. PubMed ID: 30444259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac resynchronisation therapy in patients with end-stage heart failure--long-term follow-up.
    Faran A; Lewicka-Nowak E; Dabrowska-Kugacka A; Kempa M; Tybura S; Szwoch M; Królak T; Raczak G
    Kardiol Pol; 2008 Jan; 66(1):19-26; discussion 27. PubMed ID: 18266184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.